Navidea Biopharmaceuticals Revenue Quarterly:
0.0068M for Dec. 31, 2012Navidea Biopharmaceuticals Historical Revenue Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 0.0068M |
| Sept. 30, 2012 | 0.00 |
| June 30, 2012 | 0.06M |
| March 31, 2012 | 0.0119M |
| Dec. 31, 2011 | 0.00 |
| Sept. 30, 2011 | 0.2556M |
| June 30, 2011 | 0.0061M |
| March 31, 2011 | 0.336M |
| Dec. 31, 2010 | 0.4678M |
| Sept. 30, 2010 | 0.1496M |
| June 30, 2010 | 2.539M |
| March 31, 2010 | 2.683M |
| Dec. 31, 2009 | 2.445M |
| Sept. 30, 2009 | 2.587M |
| June 30, 2009 | 1.804M |
| March 31, 2009 | 2.682M |
| Dec. 31, 2008 | 1.751M |
| Sept. 30, 2008 | 1.800M |
| June 30, 2008 | 2.255M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More
NAVB Revenue Quarterly Benchmarks
| Companies | |
|---|---|
| Abiomed | 43.67M |
| Guided Therapeutics | 1.012M |
| Span-America Medical | 16.62M |
NAVB Revenue Quarterly Rankings
| Overall |
37th percentile 4990 of 8002 |
| Sector |
22nd percentile 532 of 684 in Healthcare |
| Industry |
7th percentile 86 of 93 in Medical Devices |
NAVB Revenue Quarterly Range, Past 5 Years
| Minimum | 0.00 | Dec 2011 |
| Maximum | 2.683M | Mar 2010 |
| Average | 1.149M |
NAVB News
Navidea Biopharmaceuticals Signs Manufacturing and Supply Agreement with Nordion
Business Wire May 15
Business Wire May 15